Loading...

Biocon Q4 FY16 Financial Results by Kiran Mazumdar Shaw, CMD, Biocon.

1,041 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 27, 2016

Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, announced its Q4 & FY16 results. Kiran Mazumdar Shaw, Chairperson and Managing Director talks on Highlights and performance of Biocon.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...